282
Views
2
CrossRef citations to date
0
Altmetric
Drug Evaluations

Review of laquinimod and its therapeutic potential in multiple sclerosis

, MD & , MD
Pages 2545-2552 | Published online: 11 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jan Thöne & Ralf A Linker. (2016) Laquinimod in the treatment of multiple sclerosis: a review of the data so far. Drug Design, Development and Therapy 10, pages 1111-1118.
Read now

Articles from other publishers (1)

Anna Elgart, David J. Greenblatt, Pippa S. Loupe, Arik A. Zur, Sivan Weiss, Dorit Mimrod & Ofer Spiegelstein. (2020) The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator. Clinical Pharmacology in Drug Development 9:8, pages 1015-1024.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.